Directorate Change

Reckitt Benckiser Group PLC
12 January 2024
 

RECKITT BENCKISER GROUP PLC

DIRECTORATE CHANGE

 

Reckitt announces the appointment of

Marybeth Hays as Non-Executive Director

 

Reckitt Benckiser Group plc (the "Company" or "Reckitt") today announces the appointment of Marybeth Hays, a former Walmart senior executive, to the Board as a Non-Executive Director, effective 1 February 2024.

 

Marybeth brings more than 25 years of experience in retail, healthcare and consumer goods to the Reckitt Board. From October 2009 until February 2019, she held various roles of increasing P&L responsibility at three of the four operating divisions of Walmart, including most recently as Executive Vice President of Consumables and Health & Wellness for Walmart U.S., and as Chief Merchandising, Marketing, and Supply Chain Officer for Walmart China.  Prior to that, Marybeth served as Senior Vice President/General Merchandising Manager for two Walmart U.S. divisions and at Sam's Club, as Merchandising Vice President at Lowe's Companies, Inc., and held brand management roles as Vice President of Marketing at HanesBrands, Inc. 

 

Ms. Hays is currently a director and member of the audit committee of JOANN Stores, Inc., and serves on the board of directors for Leapfrog Brands, Affordable Care and Decowraps. Marybeth is an executive-in-residence with Kearney, and works directly with clients through her company, Hays Advising LLC. She earned both her M.B.A. and B.A. from Wake Forest University where she serves as a University Trustee and is a member of the Business School Board of Visitors.

 

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

 

"I am delighted that Marybeth has agreed to join the Reckitt Board.  She is an outstanding leader, with considerable expertise in merchandising, marketing and omnichannel gained from 25 years of general management across global retail, healthcare and consumer goods businesses. We welcome the value she will bring to the Board."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Marybeth's appointment.

 

 

Contact Details:

 

Catheryn O'Rourke                                                         +44 (0) 1753 217 800

General Counsel & Company Secretary

 

Richard Joyce                                                                +44 (0)7807 418516

Investor Relations

 

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings